AnalystsAnanda GhoshAnanda Ghosh's Stock Forecasts
AnalystsAnanda Ghosh
Sectors:
Industries:
Analyst Ranking
Top 17%
#844 out of 5186 analysts
Average Return
+52.13%
Win Rate
68%13 out of 19
Risk vs Reward
Poor
Good
Ananda Ghosh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Structure Therapeutics IncGPCR | +417.16% | $16.20 | $83.78 | 2025-08-07 - 2026-02-03 | Buy |
Maze Therapeutics IncMAZE | +171.94% | $17.64 | $47.97 | 2025-07-23 - 2026-02-03 | Buy |
Annexon IncANNX | +165.57% | $2.44 | $6.48 | 2025-08-15 - 2026-02-03 | Buy |
Maze Therapeutics IncMAZE | +105.92% | $23.30 | $47.97 | 2025-09-12 - 2026-02-03 | Buy |
Maze Therapeutics IncMAZE | +104.30% | $23.48 | $47.97 | 2025-09-18 - 2026-02-03 | Buy |
Ananda Ghosh Analyst Color
Get additional color on Ananda Ghosh's coverage of popular stocks
Ananda Ghosh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Acadia Pharmaceuticals IncACAD | 2 | Buy | $37.00 | +49.43% | Reiterates | 2 days ago |
Structure Therapeutics IncGPCR | 2 | Buy | $90.00 | +7.42% | Maintains | 2 months ago |
Stoke Therapeutics IncSTOK | 1 | Buy | $50.00 | +47.97% | Maintains | 2 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $60.00 | +216.46% | Maintains | 2 months ago |
Maze Therapeutics IncMAZE | 4 | Buy | $60.00 | +25.08% | Maintains | 2 months ago |
Pepgen IncPEPG | 3 | Buy | $20.00 | +273.13% | Maintains | 3 months ago |
Avidity Biosciences IncRNA | 2 | Hold | $72.00 | -1.28% | Downgrades | 3 months ago |
Inventiva SaIVA | 2 | Buy | $24.00 | +287.72% | Maintains | 4 months ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | +2,119.76% | Initiates Coverage On | 4 months ago |
Annexon IncANNX | 1 | Buy | $14.00 | +116.05% | Reiterates | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.